FindTrial
Sign In

Predictive value of systemic inflammatory index combined with prealbumin in postoperative pulmonary infection of lung cancer

Predictive value of systemic inflammatory index combined with prealbumin in postoperative pulmonary infection of lung cancer: a single-center retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061704
Enrollment
Unknown
Registered
2022-06-30
Start date
2022-06-30
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

no:no

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who met the lung cancer diagnosis criteria in the Chinese Code for the Diagnosis and Treatment of Primary Lung cancer (2015 edition), were diagnosed after pathological examination, had indications for surgical treatment, and underwent thoracoscopic single lobectomy + lymph node dissection; 2. Complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Radiotherapy and chemotherapy or immunosuppressants were used before enrollment; 2. Have a history of infection or antibiotics 2 weeks before admission; 3. with two or more than two sites of infection; 4. complicated with blood system diseases or other malignant tumors; 5. with heart, liver, kidney and other serious organ dysfunction; 6. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative pulmonary infection;—

Secondary

MeasureTime frame
Incidence of other postoperative complications;Postoperative hospitalization time;—

Countries

China

Contacts

Public ContactWenjing Zhao
Zhaowj886@sina.com+86 13852157285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026